CN108034666B - 沙棘gpd1基因 - Google Patents
沙棘gpd1基因 Download PDFInfo
- Publication number
- CN108034666B CN108034666B CN201711420331.0A CN201711420331A CN108034666B CN 108034666 B CN108034666 B CN 108034666B CN 201711420331 A CN201711420331 A CN 201711420331A CN 108034666 B CN108034666 B CN 108034666B
- Authority
- CN
- China
- Prior art keywords
- gpd1
- tobacco
- gene
- gpd1 gene
- seabuckthorn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000003145 Hippophae rhamnoides Nutrition 0.000 title claims abstract description 33
- 101150087371 gpd1 gene Proteins 0.000 title claims abstract description 28
- 240000000950 Hippophae rhamnoides Species 0.000 title claims description 7
- 241000208125 Nicotiana Species 0.000 abstract description 28
- 235000002637 Nicotiana tabacum Nutrition 0.000 abstract description 28
- 241000229143 Hippophae Species 0.000 abstract description 26
- 238000000034 method Methods 0.000 abstract description 19
- 241000589158 Agrobacterium Species 0.000 abstract description 12
- 239000013598 vector Substances 0.000 abstract description 12
- 241000196324 Embryophyta Species 0.000 abstract description 7
- 239000013604 expression vector Substances 0.000 abstract description 7
- 239000002299 complementary DNA Substances 0.000 abstract description 6
- 238000003259 recombinant expression Methods 0.000 abstract description 6
- 238000010276 construction Methods 0.000 abstract description 5
- 238000003208 gene overexpression Methods 0.000 abstract description 5
- 239000004519 grease Substances 0.000 abstract description 5
- 108090000623 proteins and genes Proteins 0.000 abstract description 5
- 238000009825 accumulation Methods 0.000 abstract description 4
- 230000002018 overexpression Effects 0.000 abstract description 4
- 238000011160 research Methods 0.000 abstract description 4
- 230000001131 transforming effect Effects 0.000 abstract description 4
- 238000001514 detection method Methods 0.000 abstract description 3
- 230000007246 mechanism Effects 0.000 abstract description 3
- 230000001404 mediated effect Effects 0.000 abstract description 2
- 239000003921 oil Substances 0.000 description 19
- 235000019198 oils Nutrition 0.000 description 17
- 239000001963 growth medium Substances 0.000 description 16
- 239000000843 powder Substances 0.000 description 11
- 239000007788 liquid Substances 0.000 description 10
- 230000009466 transformation Effects 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 230000004069 differentiation Effects 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 229960004793 sucrose Drugs 0.000 description 5
- 102100036669 Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic Human genes 0.000 description 4
- 101001072574 Homo sapiens Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic Proteins 0.000 description 4
- 241000208128 Nicotiana glauca Species 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- AWUCVROLDVIAJX-UHFFFAOYSA-N glycerol 1-phosphate Chemical compound OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 2
- 229960001225 rifampicin Drugs 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 238000002944 PCR assay Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 238000010805 cDNA synthesis kit Methods 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 238000003501 co-culture Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000021354 omega 7 monounsaturated fatty acids Nutrition 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/05—Oxidoreductases acting on the CH-OH group of donors (1.1) with a quinone or similar compound as acceptor (1.1.5)
- C12Y101/05003—Glycerol-3-phosphate dehydrogenase (1.1.5.3)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
本发明涉及沙棘GPD1基因,属于生物工程技术领域。该基因的构建和鉴定方法如下:(1)提取沙棘果肉RNA,并获得GPD1基因cDNA;(2)构建沙棘GPD1基因过表达载体;(3)利用沙棘GPD1基因过表达载体转化农杆菌;(4)利用pBI121‑T‑GPD1重组表达载体转化烟草;(5)转化烟草的分子检测;(6)测定烟草叶片含油率。本发明首次从沙棘果肉中分离获得GPD1基因,并通过构建过表达载体及农杆菌介导法成功转化烟草,使烟草叶片油脂含量提高28%。为沙棘果肉以及植物非种子组织油脂合成积累机制研究提供技术依据。
Description
技术领域
本发明涉及生物工程技术领域,具体涉及沙棘GPD1基因。
背景技术
木本油料的开发利用是缓解当前食用油供应不足且耕地逐渐减少的有效途径。沙棘是重要的生态经济树种,果实油脂中富含omega-3、omega-6和omega-7脂肪酸,在预防和治疗癌症、冠心病和胃肠疾病等方面具有显著疗效,但较低的含油率(种子为7~11%,鲜果肉为1~5%)制约了沙棘油的高效开发和利用。
沙棘油脂的主要成分是甘油三脂(Triacylglycerols,TAG),TAG合成的关键原料是3-磷酸甘油(glycerol-3-phosphate,G3P),而G3P是由糖酵解的中间产物磷酸二羟丙酮被3-磷酸甘油脱氢酶(glycerol-3-phosphatedehydrogenase,GPD1)还原而来,例如Vigeolas等从酵母中分离GPD1基因,通过调控种子特殊启动子活性,使GPD1活性增加2倍,油菜种子中的G3P水平增加3~4倍,种子含油量提高40%(Plant BiotechnologyJournal.2007,5:431-441)。目前,GPD1的功能研究多基于酵母、菌类和草本植物等试验材料,而在木本植物,尤其沙棘中的研究罕见,如沙棘GPD1基因序列、载体构建、遗传转化和功能分析均未见报道,而且种子油脂合成和积累机制也仍存在许多未知,如油脂合成关键基因在相对贡献、代谢流调节及代谢物在不同组织间转运等。
发明内容
为弥补现有技术的不足,本发明提供沙棘的GPD1基因序列:ATGGCTCCAGAAGCCTTCGAGTCTCACCAGGAGGAAGGTACTTTGTCCCTCTACAATGAAGTTGTTGTTGAAAAATCCAAAGTCACTGTTGTGGGTAGTGGCAATTGGGGTAGCGTGGCTGCCAAGCTTATTGCTTCCAATACCCTCAGGCTCAGCTCTTTTCATGATGAGGTGAGAATGTGGGTATTTGAGGAAACATTGCCAAGTGGAGAGAAACTCACAGATGTAATCAACCGGACCAATGAAAATGTCAAATATCTTCCAGGTATAAAGCTTGGTAAAAATGTTGTTGCTGATCCAAACCTTGAAAATGCAGCAAAGGATGCAAACATGTTGGTATTCGTAACCCCGCATCAGTTTATGGAGGATATTTGTAAAAGGCTGTTAGGGAAGATAAAAAGAGGCGTGGATGCTATATCCCTTGTTAAAGGAATGGAGGTCAAGATGGAAGGTCCTTGCATGATCTCTACTCTAATCTCCCAGCAACTGGGTGTTAATTGCTGTGTTCTAATGGGGGCAAATATAGCAAATGAGATTGCTGTGGAGAAATTTAGTGAAGCAACTGTCGGATACAGAGCAAATAGAGAGGTTGCAGAGAAATGGGTTCACCTGTTTAGTACTCCCTATTTCATTGTCACACCTGTCCAAGATGTGGAAGGAGTAGAACTATGTGGAACCCTGAAAAATGTTGTAGCTATAGCAGCAGGTTTTGTGGATGGGTTGGATATGGGAAATAACACAAAGGCTGCAATTATGAGAATTGGTCTCAGAGAGATGAAGGCATTTTCCAAATTGTTGTTTCCATCGGTCAAAGACAACACGTTCTTTGAGAGCTGTGGTGTTGCTGATCTCATTACAACATGCTTGGGAGGACG AAACAGGAAAGTTGCTGAAGCTTTTGCAAAGAATGGGGGGAATAGATCATTTGATGAGCTTGAAGCAGAAATGCTGCAAGGCCAGAAATTACAGGGTGTCTCCACAGCAAAAGAAGTTTATGAGGTTTTAACTCATCGTGGATGGCTAGAAATGTTTCCACTTTTCGCAACAGTGCAGGAGATCTGCATTGGCCGTCTCCCACCACCCGCAATAGTTCAACATGCTGAGCACAAGCTTAAATTTTCTGTGCTAGAAGGCTCTTCA。
上述基因的构建和鉴定方法如下:
(1)提取沙棘果肉RNA,并获得GPD1基因cDNA;
(2)构建沙棘GPD1基因过表达载体;
(3)利用沙棘GPD1基因过表达载体转化农杆菌;
(4)利用pBI121-T-GPD1重组表达载体转化烟草;
(5)转化烟草的分子检测;
(6)测定烟草叶片含油率。
进一步的,步骤(3):农杆菌感受态细胞制备过程中,采用含有100mg/L链霉素和100mg/L利福平的发根农杆菌培养基,在冻融法转化农杆菌过程中,采用含有100mg/L链霉素(Str)、100mg/L利福平(Rif)和50mg/L卡那霉素(Kan)的发根农杆菌培养基(YEB)。
进一步的,步骤(4)转化烟草过程中使用的MS预培养固体培养基配方为:4.74g/LMS培养基粉末、30g/L蔗糖、8g/L琼脂粉、0.5mg/L 6-苄氨基腺嘌呤(6-BA)、0.1mg/Lα.萘乙酸(NAA),pH6.0。
进一步的,步骤(4)转化烟草过程中使用的分化培养基配方为:4.74g/L MS培养基粉末、30g/L蔗糖、8g/L琼脂粉、0.5mg/L 6-苄氨基腺嘌呤(6-BA)、0.1mg/Lα.萘乙酸(NAA)、50mg/L卡那霉素(Kan)、500mg/L羧苄青霉素(Car),pH6.0。
本发明的有益效果如下:
(1)沙棘是自然界中罕有的在非种子组织中高积累油脂的植物,其果肉油脂约占干重的30%。本发明首次发现高低油品种的果肉含油率比值3.9与果肉GPD1基因表达量峰值的比值3.4相近。
(2)本发明首次从沙棘果肉中分离获得GPD1基因,并通过构建过表达载体及农杆菌介导法成功转化烟草,使烟草叶片油脂含量提高28%。这为沙棘果肉以及植物非种子组织油脂合成积累机制研究提供技术依据。
(2)农杆菌感受态细胞制备过程中,采用了含有100mg/LStr和100mg/LRif的YEB液体培养基,在冻融法转化农杆菌过程中,采用了含有100mg/LStr、100mg/LRif和50mg/LKan的YEB固体培养基,这样有效的抑制其他杂菌,减少污染,提高转化效率。
(3)烟草转化过程中,应用叶片预培养、共培养、筛选分化培养和继代生根培养过程中所使用的经过改进的MS培养基,提高了转化烟草的分化和生根效率。
附图说明
图1为重组表达载体的构建示意图;
图2转化烟草叶片的PCR检测图。
具体实施方式
下面结合实施例对本发明做进一步的说明,但不限制本发明的保护范围。
实施例1提取沙棘果肉RNA,并获得GPD1基因cDNA
收集高果肉油品系‘TF2-36’(由黑龙江省农业科学院浆果研究所培育)的成熟期果实,采摘后液氮速冻,将完好的果实剔除种子后用液氮研磨。参照上海生工公司柱式植物总RNA抽提纯化试剂盒推荐方法进行沙棘果肉总RNA提取和纯化。参照大连宝生物(TaKaRa)公司Prime Script TMII 1st Strand cDNASynthesis Kit试剂盒方法,以Oligo(dT)为引物反转录合成cDNA。以上述cDNA为模板,分别以ATGGCTCCAGAAGCCTTCGA和TGAAGAGCCTTCTAGCACAGAA为上下游引物进行PCR扩增。PCR反应体系如下:
反应程序为:94℃5min预变性;94℃变性30s,55℃退火30s,72℃延伸1min,35个循环;72℃延伸10min;4℃保存。
用1%琼脂糖凝胶电泳检测PCR产物,利用紫外凝胶成像仪上切取目的片段(大小约为1140bp)。参照TaKaRa Mini BEST Agarose Gel DNAExtraction试剂盒方法回收纯化DNA片段,并连接目的片段与克隆载体pMD18-T,测序验证获得沙棘GPD1全长cDNA。
实施例2构建沙棘GPD1基因过表达载体
根据沙棘GPD1基因序列,设计5’端分别带有BamHI和SacI限制性酶切位点的上下游引物cgGGATCCATGGCTCCAGAAGCCTTCGA和cGAGCTCTGAAGAGCCTTCTAGCACAGAA。以pMD18-T-GPD1质粒为模板,扩增含有酶切位点的目的片段。将pBI121空载体质粒以及重组质粒pMD18-T-GPD1分别用BamHI和SacI进行酶切。利用T4连接酶连接pBI121载体框架和pMD18-T-GPD1,反应体系如下:
反应程序为:16℃条件下反应6-8h。将连接产物转化大肠杆菌DH5α,在Kan抗性培养基上筛选转化子,挑取阳性克隆提取质粒进行酶切鉴定,载体图见图1所示。
实施例3利用沙棘GPD1基因过表达载体转化农杆菌
在YEB固体培养基平板上划线培养农杆菌GV3101菌株,28℃条件下倒置培养18-20h;将单菌落置于YEB液体培养基(含有100mg/LStr和100mg/LRif),28℃条件下振荡培养18-20h;100倍体积的不含抗生素的菌液加入菌液中,28℃条件下振荡培养OD600至0.3-0.5;冰上冷却后,4℃条件下4000r/min离心5min,弃上清;加入20mmol/L的CaCl2溶液使沉淀悬浮,4℃条件下4000r/min离心5min,弃上清;加入20mmol/L的CaCl2溶液再次使菌体沉淀悬浮备用。
采用冻融法,将含有重组过表达载体pBI121-T-GPD1的质粒加入到农杆菌感受态细胞GV3101中,先置于冰上10min,然后液氮速冻5min,最后37℃水浴5min。反应液与YEB液体培养基在28℃条件下培养2-3h后5000r/min离心2min,弃一部分上清,重新悬浮菌体,将其涂布于YEB固体培养基(含有100mg/L Str、100mg/L Rif和50mg/L Kan)平板上倒置培养36-48h。以阳性单菌落的菌液为模板,用GPD1基因特异性引物进行PCR检测,产物片段与目的基因大小一致,表明成功获得了含重组表达载体pBI121-GPD1的农杆菌菌株。
实施例4pBI121-T-GPD1重组表达载体转化烟草
将消毒后的烟草种子播种于MS固体培养基上,25±3℃条件下16h光照/8h黑暗培养5周。剪取烟草叶片,近轴面朝上置于MS预培养固体培养基上(4.74g/LMS培养基粉末+30g/L蔗糖+8g/L琼脂粉+0.5mg/L 6-BA+0.1mg/L NAA,pH6.0),25±3℃条件下黑暗培养2天。将烟草叶片置于含有pBI121-T-GPD1重组表达载体的农杆菌菌液中浸泡5min,然后吸干叶片表面菌液,再将其近轴面朝上重新放回培养基,25±3℃条件下黑暗共培养2天。将共培养2天的烟草叶片用含500mg/LCar的无菌水清洗两遍,无菌滤纸吸干表面液体后置于含有抗生素的MS固体筛选分化培养基上(4.74g/L MS培养基粉末+30g/L蔗糖+8g/L琼脂粉+0.5mg/L 6-BA+0.1mg/L NAA+50mg/L Kan+500mg/L Car,pH6.0),25±3℃条件下16h光照/8h黑暗进行筛选和分化培养,直到外植体切口处形成愈伤并分化出小苗。选取带有生长点且发育状态良好的抗性苗,将其切下后转移到1/2MS培养基中(2.47g/L1/2MS培养基粉末+20g/L蔗糖+8g/L琼脂条+50mg/L Kan+250mg/L Car,pH5.8)进行继代增殖和生根培养。
实施例5转化烟草的分子检测
参照天根生化科技有限公司的基因组DNA提取试剂盒方法提取未转化的野生型烟草(WT)和Kan筛选后的转化烟草的叶片基因组DNA,以上述基因组DNA为模板,利用沙棘GPD1特异性引物进行PCR扩增,反应体系及扩增条件如实施例1所述,用1%琼脂糖凝胶电泳验证目的条带大小,有5个转基因株系扩增出与目的基因大小相同的条带,而WT植株无扩增条带,如图2所示,表明GPD1基因已成功地转入烟草。
实施例6测定烟草叶片含油率
采用氯仿甲醇法,冷冻干燥的叶片粉末转移至玻璃试管中,加入甲醇和氯仿(体积浓度百分比2:1),漩涡混匀后超声30min,上清液转移到新试管中,残渣用氯仿甲醇溶液再次提取,合并的上清液,加入上清液1/4体积的氯化钾溶液(质量浓度0.88%),收集下层液至玻璃样品瓶中,挥发至恒重。含油率(%)=(m1-m2)/m×100;m1为油脂和玻璃样品瓶的质量(g);m2为玻璃样品瓶的质量(g);m为干燥样品粉末的质量(g),3次重复。
未转化的野生烟草叶片含油率约为5.02%,转化GPD1基因的烟草叶片含油率为6.43%,可见,转化沙棘GPD1基因可使烟草叶片油脂含量提高28%。
<110>大连民族大学
<120>沙棘GPD1基因
<160>1
<210>1
<211>1140
<212>DNA
<400>1
ATGGCTCCAGAAGCCTTCGAGTCTCACCAGGAGGAAGGTACTTTGTCCCTCTACAATGAAGTTGTTGTTGAAAAATCCAAAGTCACTGTTGTGGGTAGTGGCAATTGGGGTAGCGTGGCTGCCAAGCTTATTGCTTCCAATACCCTCAGGCTCAGCTCTTTTCATGATGAGGTGAGAATGTGGGTATTTGAGGAAACATTGCCAAGTGGAGAGAAACTCACAGATGTAATCAACCGGACCAATGAAAATGTCAAATATCTTCCAGGTATAAAGCTTGGTAAAAATGTTGTTGCTGATCCAAACCTTGAAAATGCAGCAAAGGATGCAAACATGTTGGTATTCGTAACCCCGCATCAGTTTATGGAGGATATTTGTAAAAGGCTGTTAGGGAAGATAAAAAGAGGCGTGGATGCTATATCCCTTGTTAAAGGAATGGAGGTCAAGATGGAAGGTCCTTGCATGATCTCTACTCTAATCTCCCAGCAACTGGGTGTTAATTGCTGTGTTCTAATGGGGGCAAATATAGCAAATGAGATTGCTGTGGAGAAATTTAGTGAAGCAACTGTCGGATACAGAGCAAATAGAGAGGTTGCAGAGAAATGGGTTCACCTGTTTAGTACTCCCTATTTCATTGTCACACCTGTCCAAGATGTGGAAGGAGTAGAACTATGTGGAACCCTGAAAAATGTTGTAGCTATAGCAGCAGGTTTTGTGGATGGGTTGGATATGGGAAATAACACAAAGGCTGCAATTATGAGAATTGGTCTCAGAGAGATGAAGGCATTTTCCAAATTGTTGTTTCCATCGGTCAAAGACAACACGTTCTTTGAGAGCTGTGGTGTTGCTGATCTCATTACAACATGCTTGGGAGGACGAAACAGGAAAGTTGCTGAAGCTTTTGCAAAGAATGGGGGGAATAGATCATTTGATGAGCTTGAAGCAGAAATGCTGCAAGGCCAGAAATTACAGGGTGTCTCCACAGCAAAAGAAGTTTATGAGGTTTTAACTCATCGTGGATGGCTAGAAATGTTTCCACTTTTCGCAACAGTGCAGGAGATCTGCATTGGCCGTCTCCCACCACCCGCAATAGTTCAACATGCTGAGCACAAGCTTAAATTTTCTGTGCTAGAAGGCTCTTCA。
<110> 大连民族大学
<120> 沙棘GPD1基因
<160> 1
<210> 1
<211> 1140
<212> DNA
<400> 1
ATGGCTCCAGAAGCCTTCGAGTCTCACCAGGAGGAAGGTACTTTGTCCCTCTACAATGAAGTTGTTGTTGAAAAATCCAAAGTCACTGTTGTGGGTAGTGGCAATTGGGGTAGCGTGGCTGCCAAGCTTATTGCTTCCAATACCCTCAGGCTCAGCTCTTTTCATGATGAGGTGAGAATGTGGGTATTTGAGGAAACATTGCCAAGTGGAGAGAAACTCACAGATGTAATCAACCGGACCAATGAAAATGTCAAATATCTTCCAGGTATAAAGCTTGGTAAAAATGTTGTTGCTGATCCAAACCTTGAAAATGCAGCAAAGGATGCAAACATGTTGGTATTCGTAACCCCGCATCAGTTTATGGAGGATATTTGTAAAAGGCTGTTAGGGAAGATAAAAAGAGGCGTGGATGCTATATCCCTTGTTAAAGGAATGGAGGTCAAGATGGAAGGTCCTTGCATGATCTCTACTCTAATCTCCCAGCAACTGGGTGTTAATTGCTGTGTTCTAATGGGGGCAAATATAGCAAATGAGATTGCTGTGGAGAAATTTAGTGAAGCAACTGTCGGATACAGAGCAAATAGAGAGGTTGCAGAGAAATGGGTTCACCTGTTTAGTACTCCCTATTTCATTGTCACACCTGTCCAAGATGTGGAAGGAGTAGAACTATGTGGAACCCTGAAAAATGTTGTAGCTATAGCAGCAGGTTTTGTGGATGGGTTGGATATGGGAAATAACACAAAGGCTGCAATTATGAGAATTGGTCTCAGAGAGATGAAGGCATTTTCCAAATTGTTGTTTCCATCGGTCAAAGACAACACGTTCTTTGAGAGCTGTGGTGTTGCTGATCTCATTACAACATGCTTGGGAGGACGAAACAGGAAAGTTGCTGAAGCTTTTGCAAAGAATGGGGGGAATAGATCATTTGATGAGCTTGAAGCAGAAATGCTGCAAGGCCAGAAATTACAGGGTGTCTCCACAGCAAAAGAAGTTTATGAGGTTTTAACTCATCGTGGATGGCTAGAAATGTTTCCACTTTTCGCAACAGTGCAGGAGATCTGCATTGGCCGTCTCCCACCACCCGCAATAGTTCAACATGCTGAGCACAAGCTTAAATTTTCTGTGCTAGAAGGCTCTTCA
Claims (1)
1.沙棘GPD1基因,其特征在于,其序列如下:
ATGGCTCCAGAAGCCTTCGAGTCTCACCAGGAGGAAGGTACTTTGTCCCTCTACAATGAAGTTGTTGTTGAAAAATCCAAAGTCACTGTTGTGGGTAGTGGCAATTGGGGTAGCGTGGCTGCCAAGCTTATTGCTTCCAATACCCTCAGGCTCAGCTCTTTTCATGATGAGGTGAGAATGTGGGTATTTGAGGAAACATTGCCAAGTGGAGAGAAACTCACAGATGTAATCAACCGGACCAATGAAAATGTCAAATATCTTCCAGGTATAAAGCTTGGTAAAAATGTTGTTGCTGATCCAAACCTTGAAAATGCAGCAAAGGATGCAAACATGTTGGTATTCGTAACCCCGCATCAGTTTATGGAGGATATTTGTAAAAGGCTGTTAGGGAAGATAAAAAGAGGCGTGGATGCTATATCCCTTGTTAAAGGAATGGAGGTCAAGATGGAAGGTCCTTGCATGATCTCTACTCTAATCTCCCAGCAACTGGGTGTTAATTGCTGTGTTCTAATGGGGGCAAATATAGCAAATGAGATTGCTGTGGAGAAATTTAGTGAAGCAACTGTCGGATACAGAGCAAATAGAGAGGTTGCAGAGAAATGGGTTCACCTGTTTAGTACTCCCTATTTCATTGTCACACCTGTCCAAGATGTGGAAGGAGTAGAACTATGTGGAACCCTGAAAAATGTTGTAGCTATAGCAGCAGGTTTTGTGGATGGGTTGGATATGGGAAATAACACAAAGGCTGCAATTATGAGAATTGGTCTCAGAGAGATGAAGGCATTTTCCAAATTGTTGTTTCCATCGGTCAAAGACAACACGTTCTTTGAGAGCTGTGGTGTTGCTGATCTCATTACAACATGCTTGGGAGGACGAAACAGGAAAGTTGCTGAAGCTTTTGCAAAGAATGGGGGGAATAGATCATTTGATGAGCTTGAAGCAGAAATGCTGCAAGGCCAGAAATTACAGGGTGTCTCCACAGCAAAAGAAGTTTATGAGGTTTTAACTCATCGTGGATGGCTAGAAATGTTTCCACTTTTCGCAACAGTGCAGGAGATCTGCATTGGCCGTCTCCCACCACCCGCAATAGTTCAACATGCTGAGCACAAGCTTAAATTTTCTGTGCTAGAAGGCTCTTCA。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711420331.0A CN108034666B (zh) | 2017-12-25 | 2017-12-25 | 沙棘gpd1基因 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711420331.0A CN108034666B (zh) | 2017-12-25 | 2017-12-25 | 沙棘gpd1基因 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108034666A CN108034666A (zh) | 2018-05-15 |
CN108034666B true CN108034666B (zh) | 2021-01-12 |
Family
ID=62101018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711420331.0A Active CN108034666B (zh) | 2017-12-25 | 2017-12-25 | 沙棘gpd1基因 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108034666B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110747201B (zh) * | 2019-11-12 | 2021-06-04 | 河南省烟草公司三门峡市公司 | 一种烟草oa1基因及引物和应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6103520A (en) * | 1993-09-03 | 2000-08-15 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Plant DNA encoding glycerol-3-phosphate dehydrogenase (GPDH) |
CN101037699A (zh) * | 2006-03-01 | 2007-09-19 | 三得利株式会社 | 3-磷酸甘油脱氢酶基因及其用途 |
CN104357415A (zh) * | 2014-10-16 | 2015-02-18 | 中国科学院遗传与发育生物学研究所 | CemGPDH基因及其应用 |
CN106479989A (zh) * | 2016-09-12 | 2017-03-08 | 中国科学院遗传与发育生物学研究所 | CectGPDH2基因及其应用 |
CN106555006A (zh) * | 2016-11-30 | 2017-04-05 | 青海大学 | 一种鉴定沙棘性别的scar分子标记及其应用 |
-
2017
- 2017-12-25 CN CN201711420331.0A patent/CN108034666B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6103520A (en) * | 1993-09-03 | 2000-08-15 | Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. | Plant DNA encoding glycerol-3-phosphate dehydrogenase (GPDH) |
CN101037699A (zh) * | 2006-03-01 | 2007-09-19 | 三得利株式会社 | 3-磷酸甘油脱氢酶基因及其用途 |
CN104357415A (zh) * | 2014-10-16 | 2015-02-18 | 中国科学院遗传与发育生物学研究所 | CemGPDH基因及其应用 |
CN106479989A (zh) * | 2016-09-12 | 2017-03-08 | 中国科学院遗传与发育生物学研究所 | CectGPDH2基因及其应用 |
CN106555006A (zh) * | 2016-11-30 | 2017-04-05 | 青海大学 | 一种鉴定沙棘性别的scar分子标记及其应用 |
Non-Patent Citations (2)
Title |
---|
Comparative transcriptome analysis of lipid biosynthesis in seeds and non-seed tissues of sea buckthorn;DING J.等;《Genes & Genomics》;20170527;第39卷;第1021-1033页 * |
沙棘果肉和种子油脂合成积累及转录表达差异研究;丁健;《中国博士学位论文全文数据库 农科科技辑》;20170215;D049-46 * |
Also Published As
Publication number | Publication date |
---|---|
CN108034666A (zh) | 2018-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111116725B (zh) | 基因Os11g0682000及其编码的蛋白在调控水稻白叶枯病抗性中的应用 | |
CN114736916B (zh) | 紫苏PfLPAT2-3基因在提高植物总脂含量中的应用 | |
CN109929852B (zh) | 杂交鹅掌楸体胚胚根伸长关键基因LhHB9及其应用 | |
CN108034666B (zh) | 沙棘gpd1基因 | |
CN108165566B (zh) | 沙棘gpd1基因的构建方法 | |
CN116731986A (zh) | 一种水稻OsLOX10基因在调节水稻盐碱胁迫抗性中的应用 | |
CN116083445A (zh) | 一种CrBZR1基因及其应用 | |
WO2011069459A1 (zh) | 一种种子特异型表达载体及其构建方法与应用 | |
CN112662688B (zh) | 核桃SnRK1蛋白激酶编码基因JrSnRK1在油脂合成与积累中的应用 | |
CN102533804B (zh) | 白沙蒿Δ12脂肪酸脱氢酶(As FAD2)基因及用途 | |
CN114085854A (zh) | 一种水稻抗旱、耐盐基因OsSKL2及其应用 | |
EP2839007B1 (en) | Methods for increasing cotton fiber length | |
CN118064497B (zh) | PfbZIP52基因的过表达载体及构建方法和在烟草中的应用 | |
CN116063433B (zh) | 一种调控油菜种子含油量的基因及应用 | |
CN114591968B (zh) | 烟草NtSCL32基因在植物分枝调控中应用 | |
CN116837000B (zh) | 一种调控菊花花期的基因、表达载体和应用 | |
CN114149993B (zh) | 一种调控植物可溶性糖含量的lncRNA及其应用 | |
CN106754932A (zh) | 一种DNA分子STTM‑miR482a及其应用 | |
CN114805513B (zh) | 烟草NtOEE1基因及其在调控茎叶夹角和株高中的应用 | |
CN114480429B (zh) | 一种抑制银杏黄酮醇苷合成的关键基因GbDAL1及其应用 | |
CN110904110B (zh) | 降低OsHAP3C基因表达在培育抽穗期推后、生育期延长水稻品种中的应用 | |
CN117402888A (zh) | 一种芒草耐盐基因MsMYB112及其应用 | |
CN112626096A (zh) | 一种创建高棕榈酸和多叶片转基因植株的方法及应用 | |
CN118497221A (zh) | 一种抗根肿病甘蓝型油菜基因Bna.BNT1及其应用 | |
CN118109509A (zh) | 一种GhBCCP1基因在调控植物种子大小中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |